Novavax
NVAX
#5858
Rank
โ‚ฌ1.07 B
Marketcap
6,56ย โ‚ฌ
Share price
-4.66%
Change (1 day)
-1.64%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -โ‚ฌ55.41 Million

According to Novavax's latest financial reports the company's current earnings are โ‚ฌ0.59 Billion. In 2025 the company made an earning of โ‚ฌ0.40 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ55.41 Million-113.56%
2025 โ‚ฌ0.40 B-396.87%
2024 -โ‚ฌ0.14 Billion-70.39%
2023 -โ‚ฌ0.47 Billion-16.59%
2022 -โ‚ฌ0.56 Billion-62.58%
2021 -โ‚ฌ1.49 Billion320.54%
2020 -โ‚ฌ0.36 Billion234.22%
2019 -โ‚ฌ0.11 Billion-30.17%
2018 -โ‚ฌ0.16 Billion1.69%
2017 -โ‚ฌ0.15 Billion-36.44%
2016 -โ‚ฌ0.24 Billion70.4%
2015 -โ‚ฌ0.14 Billion89.27%
2014 -โ‚ฌ72.8 Million59.83%
2013 -โ‚ฌ45.55 Million81.9%
2012 -โ‚ฌ25.04 Million50.33%
2011 -โ‚ฌ16.66 Million
2009 -โ‚ฌ32.88 Million8.8%
2008 -โ‚ฌ30.22 Million18.01%
2007 -โ‚ฌ25.61 Million18.33%
2006 -โ‚ฌ21.64 Million168.31%
2005 -โ‚ฌ8.07 Million-62.51%
2004 -โ‚ฌ21.52 Million52.4%
2003 -โ‚ฌ14.12 Million-28.21%
2002 -โ‚ฌ19.67 Million
2000 -โ‚ฌ11.21 Million177%
1999 -โ‚ฌ4.05 Million-11.54%
1998 -โ‚ฌ4.58 Million10.64%
1997 -โ‚ฌ4.14 Million-9.62%
1996 -โ‚ฌ4.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.87 B-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.31 B-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.89 B-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ8.80 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ21.51 M-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.28 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.10 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ7.12 Million-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.4 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ51.96 M-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA